Author： Kolassa M.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.13, Iss.2, 1998-02, pp. : 223-230
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Use of Routine Healthcare Data in Safe and Cost-Effective Drug Use
By Currie C.J.
Drug Safety, Vol. 22, Iss. 2, 2000-02 ,pp. :
Access to resources
Recommend
Losartan a "cost-effective intervention" for hypertension
Inpharma, Vol. 1, Iss. 1518, 2005-01 ,pp. :
Dutasteride "cost-effective" for BPH in Poland
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 517, 2006-01 ,pp. :
Searching for cost-effective options in Italy
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 667, 2012-01 ,pp. :
Ramipril `highly cost-effective' in Sweden
Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. :